CRP and non-small cell lung carcinoma: In the subgroup of NSCLC consisting of 16 patients in the discovery cohort and 42 patients in the validation cohort pretreatment CRP levels above 10 mg/mL were associated with shortened PFS and OS in univariate analysis, however no multivariable model was performed [27].